Watch: A Safe, Accessible Treatment for ME/CFS? The IVO-21 Study
Could IVO-21 Lead to a New ME/CFS Mitochondrial Treatment? In May 2026, Solve selected Dr. Jay H. Chung (National Institutes of Health) as a recipient of our latest ME/CFS Catalyst […]
Accelerating Severe ME/CFS Research
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes on those suffering from severe ME/CFS symptoms and advocate for better research, support, and treatment. […]
A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study
As part of our commitment to advancing science that brings real hope to people living with ME/CFS or Long Covid, Solve has selected Dr. Jay H. Chung (National Institutes of […]
New Catalyst Award Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning research studies aimed at accelerating progress toward diagnostics and treatments for ME/CFS and Long Covid. […]
